Compile Data Set for Download or QSAR
Report error Found 268 Enz. Inhib. hit(s) with all data for entry = 11309
LigandPNGBDBM605909(US11680056, Example 53A | US11680056, Example 53B)
Affinity DataIC50: 0.126nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605939(US11680056, Example 68B)
Affinity DataIC50: 0.200nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605929(US11680056, Example 63B)
Affinity DataIC50: 0.316nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605911(US11680056, Example 54A | US11680056, Example 54B)
Affinity DataIC50: 0.631nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605920(US11680056, Example 59A | US11680056, Example 59B)
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605916(US11680056, Example 57A | US11680056, Example 57B)
Affinity DataIC50: 1.26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605918(US11680056, Example 58A)
Affinity DataIC50: 1.26nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605738(US11680056, Example 4 | US11680056, Example 4B | U...)
Affinity DataIC50: 1.58nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605844(US11680056, Example 24A | US11680056, Example 24B)
Affinity DataIC50: 1.58nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605926(US11680056, Example 62A)
Affinity DataIC50: 1.58nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605936(US11680056, Example 67A)
Affinity DataIC50: 1.58nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605897(US11680056, Example 47A | US11680056, Example 47B)
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605914(US11680056, Example 56A | US11680056, Example 56B)
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605930(US11680056, Example 64A | US11680056, Example 64B)
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605838(US11680056, Example 21A | US11680056, Example 21B)
Affinity DataIC50: 3.16nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605842(US11680056, Example 23A | US11680056, Example 23B)
Affinity DataIC50: 3.16nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605924(US11680056, Example 61A | US11680056, Example 61B)
Affinity DataIC50: 3.16nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605824(US11680056, Example 9A)
Affinity DataIC50: 3.98nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605932(US11680056, Example 65A | US11680056, Example 65B)
Affinity DataIC50: 3.98nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605817(US11680056, Example 6 | US11680056, Example 6B | U...)
Affinity DataIC50: 5.01nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605873(US11680056, Example 36A)
Affinity DataIC50: 5.01nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605877(US11680056, Example 37A | US11680056, Example 37B)
Affinity DataIC50: 5.01nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605885(US11680056, Example 41A)
Affinity DataIC50: 5.01nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605899(US11680056, Example 48A | US11680056, Example 48B)
Affinity DataIC50: 5.01nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605814(US11680056, Example 5 | US11680056, Example 5A | U...)
Affinity DataIC50: 6.31nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605874(US11680056, Example 36B)
Affinity DataIC50: 6.31nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605901(US11680056, Example 49A | US11680056, Example 49B)
Affinity DataIC50: 6.31nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605935(US11680056, Example 66B)
Affinity DataIC50: 6.31nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605854(US11680056, Example 29A | US11680056, Example 29B)
Affinity DataIC50: 7.94nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605732(US11680056, Example 3 | US11680056, Example 3A | U...)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605881(US11680056, Example 39A | US11680056, Example 39B)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605916(US11680056, Example 57A | US11680056, Example 57B)
Affinity DataIC50: 10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605848(US11680056, Example 26A | US11680056, Example 26B)
Affinity DataIC50: 12.6nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605866(US11680056, Example 34B)
Affinity DataIC50: 12.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605889(US11680056, Example 43A | US11680056, Example 43B)
Affinity DataIC50: 12.6nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605903(US11680056, Example 50A | US11680056, Example 50B)
Affinity DataIC50: 12.6nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605738(US11680056, Example 4 | US11680056, Example 4B | U...)
Affinity DataIC50: 15.8nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605814(US11680056, Example 5 | US11680056, Example 5A | U...)
Affinity DataIC50: 15.8nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605869(US11680056, Example 35A | US11680056, Example 35B ...)
Affinity DataIC50: 15.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605895(US11680056, Example 46A | US11680056, Example 46B)
Affinity DataIC50: 15.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605907(US11680056, Example 52A | US11680056, Example 52B)
Affinity DataIC50: 15.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605732(US11680056, Example 3 | US11680056, Example 3A | U...)
Affinity DataIC50: 20nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605826(US11680056, Example 14)
Affinity DataIC50: 20nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605859(US11680056, Example 32A | US11680056, Example 32B ...)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605865(US11680056, Example 34A)
Affinity DataIC50: 20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605817(US11680056, Example 6 | US11680056, Example 6B | U...)
Affinity DataIC50: 25.1nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605863(US11680056, Example 33A | US11680056, Example 33B)
Affinity DataIC50: 25.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605891(US11680056, Example 44A | US11680056, Example 44B)
Affinity DataIC50: 25.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

LigandPNGBDBM605923(US11680056, Example 60B)
Affinity DataIC50: 25.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

TargetMAP kinase-activated protein kinase 2 [46-400](Human)
Xinthera

US Patent
LigandPNGBDBM605731(US11680056, Example 2)
Affinity DataIC50: 31.6nMAssay Description:This study evaluates the inhibitory potency of invention compound on p38/MK2 pathway vs p38/PRAK pathway. More specially the compound concentration (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 268 total ) | Next | Last >>
Jump to: